» Articles » PMID: 170076

Nervous System Degeneration Produced by Acrylamide Monomer

Overview
Date 1975 Jun 1
PMID 170076
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Acrylamide, widely employed as a vinyl monomer in the polymer industry, is a potent neurotoxin to man and to animals. The cumulative effect of prolonged, low-level exposure to acrylamide monomer is the insidious development of a progressive peripheral neuropathy. Sensory symptoms begin in the hands and feet (numbness, pins and needles), certain reflexes are lost and, with severe exposure, muscle weakness and atrophy occur in the extremities. The peripheral neuropathy may be supplemented by symptoms indicative of central nervous system damage (ataxia, tremor, somnolence and mental changes). The neuropathologic basis for this clinical picture has been determined in cats. Here, chronic acrylamide intoxication produces selective peripheral and central nerve fiber degeneration. Degeneration first occurs in the extremities of long and large nerve fibers which later undergo a progressive, seriate proximal axonal degeneration known as dying-back. Especially vulnerable are sensory axons supplying Pacinian corpuscles and muscle spindles in the hindfoot toepads, while adjacent motor nerve axons die back later. Distal central nerve fiber degeneration is seen in the medulla and the cerebellum. The neurotoxic property of acrylamide is of practical concern in two areas. One major problem is the protection of factory workers engaged in the manufacture of acrylamide. A sensitive test of neurologic function in these individuals, i.e., touch sensation, based on the experimental observation of the exquisite vulnerability of Pacinian corpuscles in acrylamide intoxicated cats, is presently under consideration. The second area for concern is the exposure of the populace to minute amounts of neurotoxic acrylamide monomer which contaminate acrylamide polymers currently deployed in the environment. Federal restrictions on the maximum permitted exposure to acrylamide, based on a largely clinical study of acrylamide neurotoxicity conducted ten years ago, may require a re-evaluation in the light of recent advances which have pinpointed the initial sites of nerve fiber degeneration.

Citing Articles

Neuro-reproductive toxicity and carcinogenicity of 1-bromopropane: studies for evidence-based preventive medicine.

Ichihara G J Occup Health. 2025; 67(1).

PMID: 39869365 PMC: 11847597. DOI: 10.1093/joccuh/uiaf004.


An exploratory identification of biological markers of chronic musculoskeletal pain in the low back, neck, and shoulders.

Djade C, Diorio C, Laurin D, Dionne C PLoS One. 2022; 17(4):e0266999.

PMID: 35427389 PMC: 9012384. DOI: 10.1371/journal.pone.0266999.


The Mechanism of Acrylamide-Induced Neurotoxicity: Current Status and Future Perspectives.

Zhao M, Zhang B, Deng L Front Nutr. 2022; 9:859189.

PMID: 35399689 PMC: 8993146. DOI: 10.3389/fnut.2022.859189.


Case Files of the Medical Toxicology Fellowship at the Oregon Poison Center: Thallotoxicosis.

Correia M, Lopez A J Med Toxicol. 2022; 18(3):248-255.

PMID: 35267169 PMC: 9198136. DOI: 10.1007/s13181-022-00880-9.


Peripheral Neuropathic Pain: From Experimental Models to Potential Therapeutic Targets in Dorsal Root Ganglion Neurons.

Yeh T, Luo I, Hsieh Y, Tseng T, Chiang H, Hsieh S Cells. 2020; 9(12).

PMID: 33371371 PMC: 7767346. DOI: 10.3390/cells9122725.


References
1.
Spencer P, Schaumburg H, RALEIGH R, Terhaar C . Nervous system degeneration produced by the industrial solvent methyl n-butyl ketone. Arch Neurol. 1975; 32(4):219-22. DOI: 10.1001/archneur.1975.00490460035002. View

2.
Hopkins A . The effect of acrylamide on the peripheral nervous system of the baboon. J Neurol Neurosurg Psychiatry. 1970; 33(6):805-16. PMC: 493596. DOI: 10.1136/jnnp.33.6.805. View

3.
CAVANAGH J . ORGANO-PHOSPHORUS NEUROTOXICITY: A MODEL "DYING BACK" PROCESS COMPARABLE TO CERTAIN HUMAN NEUROLOGICAL DISORDERS. Guys Hosp Rep. 1963; 112:303-19. View

4.
Hashimoto K, Ando K . Alteration of amino acid incorporation into proteins of the nervous system in vitro after administration of acrylamide to rats. Biochem Pharmacol. 1973; 22(9):1057-66. DOI: 10.1016/0006-2952(73)90170-6. View

5.
Bradley W, Williams M . Axoplasmic flow in axonal neuropathies. I. Axoplasmic flow in cats with toxic neuropathies. Brain. 1973; 96(2):235-46. DOI: 10.1093/brain/96.2.235. View